FTC sues important pharmacy benefit professionals above insulin selling prices The company introduced action versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record price of life-preserving insulin medicines. Previously this summer, the agency held prolonged negotiations with Steward about the best https://messiahukarh.blogtov.com/11127027/the-smart-trick-of-healthcare-news-that-no-one-is-discussing